Nanomicellar Prodrug Delivery of Glucose-Paclitaxel: A Strategy to Mitigate Paclitaxel Toxicity
The encapsulation of glucose-paclitaxel conjugates within nanomicelles presents a viable solution to the dose-limiting toxicities associated with paclitaxel, offering new perspectives on safety for the development of paclitaxel-based therapeutics.
Authors
- Bo Xiang (ORCID: https://orcid.org/0000-0002-0919-6121)
- Youhong Hu
- Beibei Hu (ORCID: https://orcid.org/0000-0002-6396-3854)
- Yongshuai Jing (ORCID: https://orcid.org/0000-0002-9362-4554)
- Xiaokun Cheng
- Dejun Yan
- Xi Chen (ORCID: https://orcid.org/0000-0002-3925-3684)
- Xinyue Ma (ORCID: https://orcid.org/0000-0003-3463-9809)
- Guogang Zhang (ORCID: https://orcid.org/0000-0002-8678-2167)
Institutions
- Southwest Medical University (CN)
- Hebei University of Science and Technology (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- Hebei Chemical and Pharmaceutical College (CN)
- Shijiazhuang Yiling Pharmaceutical (China) (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/ijn.s500999
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Hebei Province